Hims & Hers posts best weekly gain after Novo deal [Seeking Alpha]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Seeking Alpha
months-long dispute with Novo Nordisk ( NVO ) and agreed to sell the pharma giant's brand-name weight-loss drugs on its platform. The Fresh Stock Ideas, Every Day Explore diverse investing perspectives with daily analysis from experts across the market. Subscribe to Stock Ideas Sign Up Quick Insights The new agreement to sell Novo's brand-name weight-loss drugs boosts credibility and product offering, but limits marketing of compounded versions. Analyst reactions are mixed: several upgrades occurred due to reduced risk, but overall Wall Street rating remains Hold and Seeking Alpha's quant system rates as Strong Sell, while most SA analysts remain bullish. Risks include limited ability to advertise compounded drugs, potential regulatory scrutiny, and divided sentiment among major analyst rating systems. More Trending News
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- When generic versions of weight-loss drugs arrive, public plans should cover them, experts say [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- FDA: Novo Nordisk failed to report deaths of weight-loss drug patients [USA TODAY]USA TODAY
- Novo Nordisk Patent Loss In India Tests GLP 1 Valuation Story [Yahoo! Finance]Yahoo! Finance
- Eli Lilly Just Opened the Door to Even Greater GLP-1 Growth [Yahoo! Finance]Yahoo! Finance
- Why the Novo Nordisk and Hims & Hers Deal Is a Win for Both Stocks [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 2/3/26 - Beat
NVO
Sec Filings
- 3/9/26 - Form 6-K
- 3/2/26 - Form 6-K
- 3/2/26 - Form 6-K
- NVO's page on the SEC website